Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03367260 · ClinicalTrials.gov registry record
The Treatment Preferences of Women Diagnosed With Ovarian Cancer
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 115
- Enrollment target
NCT03367260 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 115 participants.
The verdict
NCT03367260 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 115 participants
- Enrollment target
Study Summary
The primary objective of this study is to apply best-practice stated-preference methods to quantify the extent to which women with ovarian cancer accept the risks, side effects, and out-of-pocket costs associated with treatment in return for progression-free survival benefit afforded by a treatment, regardless of whether there is an overall survival benefit.
Interventions
- OTHER Preference Elicitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2017-10-19 |
| Est. Completion | 2019-01-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03367260
The ClinicalTrials.gov registry entry for NCT03367260 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Preference Elicitation is the first listed.
NCT03367260 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03367260 about?
NCT03367260 is a clinical study titled "The Treatment Preferences of Women Diagnosed With Ovarian Cancer". The primary objective of this study is to apply best-practice stated-preference methods to quantify the extent to which women with ovarian cancer accept the risks, side effects, and out-of-pocket costs associated with treatment in return for progression-free survival benefit afforded by a treatment,...
What is the current status of trial NCT03367260?
This trial is currently completed. The enrollment target is 115 participants. The study started on 2017-10-19. Estimated completion is 2019-01-04.
What interventions are being tested in trial NCT03367260?
The interventions under investigation include: Preference Elicitation (OTHER).
Who is sponsoring clinical trial NCT03367260?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.